Paper Details 
Original Abstract of the Article :
EGFR tyrosine kinase inhibitors (TKIs) are the front-line treatment in <i>EGFR</i> mutation positive advanced non-small cell lung cancer (aNSCLC) patients. Generally, they are well-tolerated but skin toxicity is common (45-100% of patients) and may adversely affect quality of life. Pathogenesis of c...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220808/

データ提供:米国国立医学図書館(NLM)

A Skin-Deep Mystery: EGFR-TKIs and Subacute Cutaneous Lupus Erythematosus-Like Eruption

Targeted cancer therapies have revolutionized the treatment landscape, offering new hope for patients with advanced diseases. However, these therapies are not without side effects. This case report delves into a rare and unexpected complication, subacute cutaneous lupus erythematosus-like eruption, induced by EGFR tyrosine kinase inhibitors (TKIs), a class of drugs used to treat non-small cell lung cancer.

A Twist in the Tale: Unraveling the Unexpected

The authors describe a patient who developed subacute cutaneous lupus erythematosus-like eruption after treatment with erlotinib and osimertinib, two EGFR-TKIs. This case highlights the importance of carefully monitoring patients receiving these therapies, recognizing that even rare and unexpected side effects can occur. It's like stumbling upon a hidden oasis in the desert, an unexpected discovery that demands attention and investigation.

Navigating the Side Effects: A Comprehensive Approach

The authors emphasize the importance of a complete dermatologic diagnosis of skin lesions induced by EGFR inhibitors, particularly in the context of immune-related toxicity. This underscores the need for a comprehensive approach to managing side effects, considering both the underlying cause and the potential for systemic involvement. It's like a skilled camel guide, navigating a complex desert landscape, understanding the terrain and adapting to changing conditions.

Dr.Camel's Conclusion

This case report provides a valuable reminder of the potential for rare and unexpected side effects with EGFR-TKIs. It highlights the importance of careful monitoring and a comprehensive approach to managing skin toxicity, recognizing that these therapies can have both beneficial and potentially harmful effects. Like a camel caravan traversing a vast and unforgiving desert, we must be prepared for the unexpected and adapt to the challenges that lie ahead.

Date :
  1. Date Completed n.d.
  2. Date Revised 2021-06-29
Further Info :

Pubmed ID

34179028

DOI: Digital Object Identifier

PMC8220808

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.